BR112015020332A2 - processos de engenharia química e aparelhos para a síntese de compostos - Google Patents

processos de engenharia química e aparelhos para a síntese de compostos

Info

Publication number
BR112015020332A2
BR112015020332A2 BR112015020332A BR112015020332A BR112015020332A2 BR 112015020332 A2 BR112015020332 A2 BR 112015020332A2 BR 112015020332 A BR112015020332 A BR 112015020332A BR 112015020332 A BR112015020332 A BR 112015020332A BR 112015020332 A2 BR112015020332 A2 BR 112015020332A2
Authority
BR
Brazil
Prior art keywords
cannabinoid
compounds
synthesis
chemical engineering
engineering processes
Prior art date
Application number
BR112015020332A
Other languages
English (en)
Portuguese (pt)
Inventor
Donsky Marc
Winnicki Robert
Original Assignee
Full Spectrum Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Full Spectrum Laboratories Ltd filed Critical Full Spectrum Laboratories Ltd
Publication of BR112015020332A2 publication Critical patent/BR112015020332A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/24Preparation of oxygen-containing organic compounds containing a carbonyl group
    • C12P7/26Ketones
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01HNEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
    • A01H6/00Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
    • A01H6/28Cannabaceae, e.g. cannabis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/658Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M21/00Bioreactors or fermenters specially adapted for specific uses
    • C12M21/18Apparatus specially designed for the use of free, immobilized or carrier-bound enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/30Means for regulation, monitoring, measurement or control, e.g. flow regulation of concentration
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/48Automatic or computerized control
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1025Acyltransferases (2.3)
    • C12N9/1029Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • C12P17/06Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/02Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/04Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/02Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/22Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/40Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • C12P7/42Hydroxy-carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/62Carboxylic acid esters
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y121/00Oxidoreductases acting on X-H and Y-H to form an X-Y bond (1.21)
    • C12Y121/03Oxidoreductases acting on X-H and Y-H to form an X-Y bond (1.21) with oxygen as acceptor (1.21.3)
    • C12Y121/03007Tetrahydrocannabinolic acid synthase (1.21.3.7)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y121/00Oxidoreductases acting on X-H and Y-H to form an X-Y bond (1.21)
    • C12Y121/03Oxidoreductases acting on X-H and Y-H to form an X-Y bond (1.21) with oxygen as acceptor (1.21.3)
    • C12Y121/03008Cannabidiolic acid synthase (1.21.3.8)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y203/00Acyltransferases (2.3)
    • C12Y203/01Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • C12Y203/012063,5,7-Trioxododecanoyl-CoA synthase (2.3.1.206)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y205/00Transferases transferring alkyl or aryl groups, other than methyl groups (2.5)
    • C12Y205/01Transferases transferring alkyl or aryl groups, other than methyl groups (2.5) transferring alkyl or aryl groups, other than methyl groups (2.5.1)
    • C12Y205/01102Geranyl-pyrophosphate—olivetolic acid geranyltransferase (2.5.1.102)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Sustainable Development (AREA)
  • Analytical Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Computer Hardware Design (AREA)
  • Developmental Biology & Embryology (AREA)
  • Physiology (AREA)
  • Botany (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Environmental Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Enzymes And Modification Thereof (AREA)
BR112015020332A 2013-02-28 2014-02-27 processos de engenharia química e aparelhos para a síntese de compostos BR112015020332A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361770766P 2013-02-28 2013-02-28
PCT/US2014/018944 WO2014134281A1 (en) 2013-02-28 2014-02-27 Biosynthesis of cannabinoids

Publications (1)

Publication Number Publication Date
BR112015020332A2 true BR112015020332A2 (pt) 2017-07-18

Family

ID=51428796

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015020332A BR112015020332A2 (pt) 2013-02-28 2014-02-27 processos de engenharia química e aparelhos para a síntese de compostos

Country Status (9)

Country Link
US (8) US9359625B2 (https=)
EP (1) EP2961402B1 (https=)
JP (3) JP6581509B2 (https=)
CN (1) CN105555265A (https=)
AU (2) AU2014223458A1 (https=)
BR (1) BR112015020332A2 (https=)
CA (2) CA3012383C (https=)
IL (1) IL240830B (https=)
WO (1) WO2014134281A1 (https=)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014134281A1 (en) 2013-02-28 2014-09-04 Full Spectrum Laboratories Limited Biosynthesis of cannabinoids
US9822384B2 (en) 2014-07-14 2017-11-21 Librede Inc. Production of cannabinoids in yeast
US11293038B2 (en) 2014-07-14 2022-04-05 Librede Inc. Production of cannabinoids in yeast
US9394510B2 (en) * 2014-08-25 2016-07-19 Full Spectrum Laboratories Limited Apparatus and methods for the simultaneous production of compounds
CN107205960A (zh) 2014-10-21 2017-09-26 联合大麻公司 大麻提取物及其制备和使用方法
MX385464B (es) 2014-12-12 2025-03-18 Ojai Energetics Pbc Composiciones microencapsuladas de cannabinoides
US10350165B2 (en) 2014-12-12 2019-07-16 Ojai Energetics Pbc Methods and systems for forming stable droplets
CA3019890A1 (en) 2016-04-04 2017-10-12 Teewinot Technologies Limited Bioenzymatic synthesis of tetrahydrocannabivarin (thc-v), cannabinol (cbn), and cannabivarin (cbv) and their use as therapeutic agents
AU2017250303B2 (en) * 2016-04-15 2019-09-26 Teewinot Technologies Limited Biosynthesis of cannabinoid prodrugs
EP3928776B1 (en) 2016-04-22 2025-11-12 Spoke Sciences, Inc. Fast-acting plant-based medicinal compounds and nutritional supplements
JP7454332B2 (ja) * 2016-06-15 2024-03-22 オーハイ エナジェティクス ピービーシー 酸化ストレスを低減するための方法および組成物
WO2018091551A1 (en) * 2016-11-15 2018-05-24 Full Spectrum Laboratories Ltd Bio-stable cannabinoid compounds and methods for enhancing their physiological concentration
EA201892396A1 (ru) 2016-12-02 2019-04-30 Ресептор Лайф Сайенсиз, Инк. Быстродействующие растительные лекарственные соединения и биологически активные добавки
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
EP3583222A4 (en) 2017-02-17 2021-01-13 Hyasynth Biologicals Inc. PROCESS AND CELL LINE FOR THE MANUFACTURE OF PHYTOCANNABINOIDS AND PHYTOCANNABINOID ANALOGA IN YEAST
CA3056929A1 (en) 2017-03-24 2018-09-27 Trait Biosciences, Inc. High level in vivo biosynthesis and isolation of water-soluble cannabinoids in plant systems
AU2018260710B2 (en) * 2017-04-26 2022-07-21 Teewinot Technologies Limited Apparatus, methods and composition for synthesis of cannabinoid compounds
CN110914416B (zh) 2017-04-27 2023-07-21 加州大学董事会 产生大麻素和大麻素衍生物的微生物和方法
US11946059B2 (en) 2017-07-11 2024-04-02 Trait Biosciences, Inc. In vivo generation of water-soluble cannabinoids in plant cell suspension cultures
CA3069178A1 (en) 2017-07-11 2019-01-17 Trait Biosciences, Inc. Generation of water-soluble cannabinoid compounds in yeast and plant cell suspension cultures and compositions of matter
US11905543B2 (en) 2017-07-11 2024-02-20 Trait Biosceinces, Inc. In vivo generation of water-soluble acetylated cannabinoid glycoside compounds in plant cell suspension cultures
JP2020530308A (ja) 2017-07-12 2020-10-22 バイオメディキャン, インコーポレイテッド 酵母におけるカンナビノイドの生成
EP3679146A4 (en) 2017-09-05 2021-06-16 Inmed Pharmaceuticals Inc. E. COLI PATHWAY DESIGN FOR THE BIOSYNTHESIS OF CANNABINOID PRODUCTS
WO2019070876A2 (en) 2017-10-03 2019-04-11 The Regents Of The University Of Colorado METHOD FOR DIFFERENTIATING CANNABIS PLANT CULTIVARS BASED ON CANNABINOID SYNTHASE PARALOGUES
KR102398709B1 (ko) 2017-10-20 2022-05-16 제이에프이 스틸 가부시키가이샤 고강도 강판 및 그 제조 방법
EP3745884A1 (en) 2018-01-31 2020-12-09 Canopy Holdings, Llc Hemp powder
US20210238561A1 (en) 2018-04-23 2021-08-05 Renew Biopharma, Inc. Enzyme engineering to alter the functional repertoire of cannabinoid synthases
US10801049B2 (en) 2018-06-14 2020-10-13 Syntiva Therapeutics, Inc. Genetically engineered microorganisms and processes for the production of cannabinoids from a carbon source precursor
CA3119729A1 (en) * 2018-10-10 2020-04-16 Treehouse Biotech, Inc. Synthesis of cannabigerol
WO2020089424A1 (en) 2018-10-31 2020-05-07 Enantia, S.L. Solid compositions of cocrystals of cannabinoids
AU2019385420A1 (en) 2018-11-19 2021-07-08 Spoke Sciences, Inc. N-acylated fatty amino acids to reduce absorption variability in cannabinoid based compositions
CN109734591A (zh) * 2018-12-26 2019-05-10 江苏暨明医药科技有限公司 一种大麻二酚中间体及其制备方法与及应用
CA3130763A1 (en) 2019-02-25 2020-09-03 Ginkgo Bioworks, Inc. Biosynthesis of cannabinoids and cannabinoid precursors
CA3129535A1 (en) 2019-03-07 2020-09-10 Oludare ODUMOSU Formulations for treating cluster symptoms associated with autism spectrum disorder
US12540315B2 (en) 2019-04-12 2026-02-03 Renew Biopharma, Inc. Compositions and methods for using genetically modified enzymes
CA3140079A1 (en) * 2019-05-22 2020-11-26 Demetrix, Inc. Optimized cannabinoid synthase polypeptides
ES3037766T3 (en) 2019-06-11 2025-10-07 Symrise Ag Synthesis and purification of cannabigerol and its application
US10717056B1 (en) 2019-09-09 2020-07-21 Michael Cem Gokay Method and apparatus for purification of cannabinoid extracts
JP2022551476A (ja) * 2019-10-08 2022-12-09 ベッソール ファルマ、エルエルシー カンナビノイド及びカンナビノイド酸の製造プロセス
CN114599787B (zh) * 2019-10-11 2025-02-28 新加坡国立大学 利用酿酒酵母(Saccharomyces Cerevisiae)从简单前体原料可持续生产大麻素
KR20220079578A (ko) 2019-10-11 2022-06-13 내셔널 유니버시티 오브 싱가포르 신규 칸나비노이드 신타아제를 사용한 칸나비게롤산으로부터 칸나비노이드의 생합성
EP4136220A4 (en) 2020-04-14 2024-06-05 Genomatica, Inc. CANNABINOID SYNTHASE VARIANTS AND METHODS OF USE THEREOF
WO2021226711A1 (en) * 2020-05-12 2021-11-18 Canopy Growth Corporation Methods of synthesizing cannabigergol, cannabigerolic acid, and analogs thereof
CA3132439A1 (en) 2020-05-12 2021-11-12 Canopy Growth Corporation Methods of synthesizing cannabigergol, cannabigerolic acid, and analogs thereof
WO2022147270A1 (en) 2020-12-31 2022-07-07 Cookies Creative Consulting & Promotions, Inc. Compositions comprising cannabis and mushroom extracts, and uses thereof
US20220298533A1 (en) * 2021-03-22 2022-09-22 Cb Therapeutics, Inc. Biosynthetic methods for the modification of cannabinoids
WO2022256691A1 (en) * 2021-06-04 2022-12-08 Amyris, Inc. Methods of purifying cannabinoid
US20250027127A1 (en) * 2021-09-15 2025-01-23 The Regents Of The University Of California Cannabinoid production in bacteria

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5086646A (en) 1989-09-12 1992-02-11 Jamison Dale E Apparatus and method for analyzing well fluid sag
US5290701A (en) * 1991-08-28 1994-03-01 Wilkins Judd R Microbial detection system and process
US5302525A (en) * 1992-11-23 1994-04-12 National Research Council Of Canada Methylobacterium extorquwns microorganism useful for the preparation of poly-β-hydroxybutyric acid polymers
US7530461B2 (en) * 1995-03-10 2009-05-12 Photocure Asa Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
US6113940A (en) 1997-03-03 2000-09-05 Brooke; Lawrence L. Cannabinoid patch and method for cannabis transdermal delivery
JP2000078979A (ja) 1998-09-04 2000-03-21 Taisho Pharmaceut Co Ltd テトラヒドロカンナビノール酸シンターゼ遺伝子
AR022383A1 (es) * 1998-09-18 2002-09-04 Univ Kentucky Res Found Sintasas
US6403126B1 (en) 1999-05-26 2002-06-11 Websar Innovations Inc. Cannabinoid extraction method
US6949582B1 (en) 1999-05-27 2005-09-27 Wallace Walter H Method of relieving analgesia and reducing inflamation using a cannabinoid delivery topical liniment
JP2001029082A (ja) * 1999-07-22 2001-02-06 Yukihiro Masayama カンナビジオール酸シンターゼをコードするdna
US6730330B2 (en) 2001-02-14 2004-05-04 Gw Pharma Limited Pharmaceutical formulations
US6946150B2 (en) 2002-08-14 2005-09-20 Gw Pharma Limited Pharmaceutical formulation
WO2004016254A2 (en) 2002-08-16 2004-02-26 Immugen Pharmaceuticals, Inc. Contraceptive methods and formulations
GB0222077D0 (en) 2002-09-23 2002-10-30 Gw Pharma Ltd Methods of preparing cannabinoids from plant material
DE10335130A1 (de) * 2003-07-31 2005-02-24 Blue Membranes Gmbh Immobilisierung von Katalysatoren auf porösen Körpern auf Kohlenstoffbasis
GB2418612A (en) 2004-10-01 2006-04-05 Gw Pharma Ltd Inhibition of tumour cell migration with cannabinoids
US7361483B2 (en) * 2005-01-28 2008-04-22 The Salk Institute For Biological Studies Aromatic prenyltransferases, nucleic acids encoding same and uses therefor
MX2007011125A (es) 2005-04-01 2007-10-23 Basf Ag Uso de proteinas como agentes de desemulsionantes.
WO2006124801A2 (en) * 2005-05-12 2006-11-23 The University Of North Carolina At Chapel Hill Enzymatic synthesis of sulfated polysaccharides
JP2007020466A (ja) 2005-07-15 2007-02-01 Institute Of Physical & Chemical Research 大麻CannabissativaL.の識別方法
US9265724B2 (en) 2005-11-07 2016-02-23 Ram B. Murty Oral dosage form of tetrahydrocannabinol and a method of avoiding and/or suppressing hepatic first pass metabolism via targeted chylomicron/lipoprotein delivery
PT1903866E (pt) 2005-11-07 2016-06-09 Murty Pharmaceuticals Inc Distribuição melhorada de tetra-hidrocanabinol
GB2434312B (en) 2006-01-18 2011-06-29 Gw Pharma Ltd Cannabinoid-containing plant extracts as neuroprotective agents
GB2450493A (en) * 2007-06-25 2008-12-31 Gw Pharma Ltd Cannabigerol for use in treatment of diseases benefiting from agonism of CB1 and CB2 cannabinoid receptors
WO2009102466A1 (en) 2008-02-14 2009-08-20 The General Hospital Corporation Well-based flow system for cell culture
GB2459125B (en) 2008-04-10 2013-01-02 Gw Pharma Ltd Method if extracting cannabichromene and its acid from Cannabis sativa plant material
US9921576B2 (en) * 2008-05-05 2018-03-20 Finesse Solutions, Inc. Virtual transmitter for bioreactor automation system
ES2656776T3 (es) * 2008-06-13 2018-02-28 N.V. Nutricia Composición nutricional para bebés nacidos por cesárea
US8158394B2 (en) 2009-04-08 2012-04-17 Bristol-Myers Squibb Company Genetically stable plasmid expressing PDH and FDH enzymes
DE102009019322A1 (de) * 2009-04-30 2010-11-11 The Health Concept Gmbh Verfahren zur Herstellung von Synthetischen Cannabinoiden
WO2010129574A1 (en) 2009-05-04 2010-11-11 The Regents Of The University Of California Stress-tolerant plants expressing mannosylglycerate-producing enzymes
US20110003703A1 (en) * 2009-07-01 2011-01-06 Charles Ma Nucleic Acid Hybridization and Detection Using Enzymatic Reactions on a Microarray
CA2770774C (en) 2009-08-12 2020-07-14 National Research Council Of Canada Aromatic prenyltransferase from cannabis
PE20121336A1 (es) * 2009-12-01 2012-11-03 Abbvie Inc Nuevos compuestos triciclicos
GB2478595B (en) 2010-03-12 2018-04-04 Gw Pharma Ltd Phytocannabinoids in the treatment of glioma
CA3130705A1 (en) * 2010-04-15 2011-10-20 National Research Council Of Canada Genes and proteins for aromatic polyketide synthesis
JP5751661B2 (ja) 2010-11-02 2015-07-22 国立研究開発法人農業・食品産業技術総合研究機構 デキストラングルカナーゼ
JP2012130294A (ja) 2010-12-22 2012-07-12 Tosoh Corp 抗体結合タンパク質およびその製造方法
US8808734B2 (en) * 2011-07-11 2014-08-19 Full Spectrum Laboratories Limited Cannabinoid formulations
AU2012283708B2 (en) 2011-07-13 2017-02-23 National Research Council Of Canada Genes and proteins for alkanoyl-CoA synthesis
US20140057251A1 (en) 2011-08-18 2014-02-27 Medicinal Genomics Corporation Cannabis Genomes and Uses Thereof
GB2494461A (en) 2011-09-12 2013-03-13 Gw Pharma Ltd Phytocannabinoids for use in the treatment of invasive cancers or metastases
GB2495118B (en) 2011-09-29 2016-05-18 Otsuka Pharma Co Ltd A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
GB2496688B (en) 2011-11-21 2016-06-29 Gw Pharma Ltd Tetrahydrocannabivarin for use in the treatment of intestinal inflammatory diseases
JP6118892B2 (ja) 2012-03-30 2017-04-19 ザ スクリプス リサーチ インスティテュート デュオカルマイシン類縁体の環式プロドラッグ
AU2013257322A1 (en) 2012-05-03 2014-11-20 Echo Pharmaceuticals B.V. Cannabis plant isolate comprising delta9-tetrahydrocannabinol and a method for preparing such an isolate
WO2014134281A1 (en) 2013-02-28 2014-09-04 Full Spectrum Laboratories Limited Biosynthesis of cannabinoids
US9095554B2 (en) 2013-03-15 2015-08-04 Biotech Institute LLC Breeding, production, processing and use of specialty cannabis
ES2525137B1 (es) 2013-06-13 2016-01-18 Servicio Andaluz De Salud Agentes para tratar el mieloma múltiple
US10214718B2 (en) 2013-07-01 2019-02-26 University Of Massachusetts Distributed perfusion bioreactor system for continuous culture of biological cells
US9326967B2 (en) 2013-08-22 2016-05-03 Stephen C. Perry Vaporizable cannabinoid compositions
US9655910B2 (en) 2014-03-21 2017-05-23 Bodybio Inc. Compositions and methods for treating addiction
EP3171872B1 (en) * 2014-07-21 2020-11-11 Glia, LLC Method for treating radiotherapy-and-chemotherapy associated cognitive or emotional impairment with cannabinoids
US9394510B2 (en) 2014-08-25 2016-07-19 Full Spectrum Laboratories Limited Apparatus and methods for the simultaneous production of compounds
AU2018260710B2 (en) * 2017-04-26 2022-07-21 Teewinot Technologies Limited Apparatus, methods and composition for synthesis of cannabinoid compounds

Also Published As

Publication number Publication date
AU2014223458A1 (en) 2015-10-15
EP2961402A4 (en) 2016-11-23
US20160355854A1 (en) 2016-12-08
US20170152530A1 (en) 2017-06-01
CA2902452A1 (en) 2014-09-04
US10472652B2 (en) 2019-11-12
AU2018228329A1 (en) 2018-09-27
US10081818B2 (en) 2018-09-25
EP2961402B1 (en) 2024-10-02
US20170159080A1 (en) 2017-06-08
US20200048664A1 (en) 2020-02-13
US10214753B2 (en) 2019-02-26
US20150361469A1 (en) 2015-12-17
CN105555265A (zh) 2016-05-04
CA3012383A1 (en) 2014-09-04
US20180230499A1 (en) 2018-08-16
JP6724052B2 (ja) 2020-07-15
EP2961402A1 (en) 2016-01-06
US20160355853A1 (en) 2016-12-08
US9359625B2 (en) 2016-06-07
IL240830A0 (en) 2015-10-29
WO2014134281A1 (en) 2014-09-04
US9526715B1 (en) 2016-12-27
JP2020022507A (ja) 2020-02-13
US9861609B2 (en) 2018-01-09
JP2016509842A (ja) 2016-04-04
US20170247650A1 (en) 2017-08-31
CA3012383C (en) 2021-03-02
JP2018086012A (ja) 2018-06-07
JP6581509B2 (ja) 2019-09-25
IL240830B (en) 2022-08-01
CA2902452C (en) 2018-09-04

Similar Documents

Publication Publication Date Title
BR112015020332A2 (pt) processos de engenharia química e aparelhos para a síntese de compostos
BR112014030365A2 (pt) síntese de composto antiviral
BR112015017606A2 (pt) composição, método de produzir a composição, utilização da composição e combustível obtido a partir da composição
BR112015000994A2 (pt) processo e sistema de reação para a preparação de metanol
MX2017006382A (es) Analogos de eter fosfolipidico como portadores de farmacos dirigidos a cancer.
MX2015002616A (es) Sintesis de bis(fluorosulfonil)imida.
BR112016028773A2 (pt) processos para preparação de compostos antivirais
MX377552B (es) Proceso para preparar un compuesto antiviral de formula i.
BR112013020513A2 (pt) adoçante stevia altamente solúvel
BR112014019909A8 (pt) Processo para produção de compostos úteis como antagonistas do receptor de orexina-2
BR112014021938A8 (pt) metodo para produzir composto epóxi contendo enxofre
BR112018016887A2 (pt) método para fabricação de ciclododecaenxofre.
CL2016000382A1 (es) Procesos para preparar compuestos antivirales
BR112013016578A2 (pt) processo para preparar metilmercaptopropionaldeídeo
BR112017008521A2 (pt) processo para fabricar um ou mais composto(s) benzoxazina, processo de síntese, e, composições de produto da reação e de resina curável.
BR112018077149A2 (pt) processo para produção de anilina ou outros produtos derivados da anilina
MX2017011407A (es) Metodo para producir esteres de tetrahidropiranilo.
MX2015015151A (es) Metodo para producir 4-hidroxi-4-metil-tetrahidropiranos 2-sustituidos, donde dicho proceso usa reciclado.
BR112013027976A2 (pt) processos e intermediários na preparação de análogos de morfina através da n-desmetilação dos n-óxidos utilizando os reagentes de ciclodesidratação
BR112017025021A2 (pt) ?processo para a produção de poliuretanos, poliuretano e uso de um poliuretano?
MX2016000390A (es) Proceso para fabricar haloacetamidas.
BR112017006470A2 (pt) processo para revestimento homogêneo de substratos (1) para a produção de catalisadores para purificação de gases de escapamento
BR112012021574A2 (pt) processo para preparação de amônia.
BR112015018222A2 (pt) método para produzir um composto tricíclico, e composto tricíclico que pode ser produzido pelo referido método de produção
BR112012020399A2 (pt) solução de acrilamida aquosa estável

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B25D Requested change of name of applicant approved

Owner name: TEEWINOT TECHNOLOGIES LIMITED (IE)

B07F Notification of approval that there is no relation to art. 229 of lpi (pipeline patents) [chapter 7.6 patent gazette]
B11R Patent application dismissed according to article 229 of the patent law [chapter 11.18 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2619 DE 16-03-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.